Drug Information

Drug General Information
Drug ID
D03QLG
Former ID
DNC000398
Drug Name
CEP1347
Drug Type
Small molecular drug
Indication Asthma [ICD10:J45] Phase 2/3 [527447]
Structure
Download
2D MOL

3D MOL
Formula
C33H33N3O5S2
Canonical SMILES
CCSCC1=CC2=C(C=C1)N3C4CC(C(O4)(N5C6=C(C=C(C=C6)CSCC)C7=<br />C8CNC(=O)C8=C2C3=C75)C)C(=O)OOC
InChI
1S/C33H33N3O5S2/c1-5-42-15-17-7-9-23-19(11-17)27-28-21(14-34-31(28)37)26-20-12-18(16-43-6-2)8-10-24(20)36-30(26)29(27)35(23)25-13-22(32(38)41-39-4)33(36,3)40-25/h7-12,22,25H,5-6,13-16H2,1-4H3,(H,34,37)/t22-,25+,33+/m1/s1
InChIKey
WMBUVOLZSWTKMP-KQFGJPIXSA-N
CAS Number
CAS 156177-65-0
PubChem Compound ID
133005
PubChem Substance ID
29311018, 50514409, 53787793, 57344345, 104378762, 135088073, 137267228, 175426995, 227838827
Target and Pathway
Target(s) Mitogen-activated protein kinase kinase kinase 9 Target Info Inhibitor [535353]
WikiPathways Insulin Signaling
p38 MAPK Signaling Pathway
References
Ref 527447Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):63-7.
Ref 535353Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.